Family was such an important part of Jerry’s life. He wanted to spend every minute he could with each one of us. He never took anyone for granted and appreciated everyone.
Dad always struggled with weight loss. He would go up then down, he tried every diet.
Never did he complain of heartburn. Even though dad enjoyed eating he NEVER drank or smoked so when he told us that November 2004 he had been diagnosed with esophageal cancer we were all in shock. Eight months later dad was taken from us at the age of 50 after undergoing radiation, chemo and surgery.
It is so difficult to comprehend the death of anyone, let alone your father. Trying to make peace with it has been hard but watching someone suffer is even harder. We thank God for giving him the peace that he so needed and know he continues to look down on us and protect us.
We now look back on the time we had with him and remember all those great family outings we went on, trips into the city, vacations and get-togethers at someone’s house. He enjoying hearing about your life daily and was always someone who was there for you.
Jerry was a member of the financial world and made many friends along the way. It was an honor to see how many hearts Jerry touched when people came to give their final respects.
We started the Jerry D’Amato Charity Foundation to celebrate Jerry’s love for life and to help fund esophageal cancer research at Johns Hopkins Medical Center. Our family is committed to spreading the word about early detection and to help fund research that isolates the gene that leads to this horrible disease.
Please remember to go for your yearly checkups and to try and eat healthy. We are fighting a tough battle and are appreciative of any support.
The Jerry D’Amato Charity Foundation
Founded in December 2005, the Jerry D’Amato Charity Foundation was able to sponsor Dr. Hector Alvarez from Santiago, Chile. Dr. Anirban Maitra and Dr. Elizabeth Montgomery are jointly mentoring Hector Alvarez to study the molecular genetics and targeted therapy of esophageal adenocarcinoma.
Dr. Montgomery is a senior clinician/pathologist at Johns Hopkins and Dr. Maitra is an Associate Professor of Pathology, Oncology and Genetic Medicine at Johns Hopkins.
The foundation has also made the following Experiments possible:
- Serial Analysis of Gene Expression in the Barrett esophagus progression model
- Integrative Epigenomics of the Barrett esophagus progression model
- Mesothelin targeted diagnosis and therapy of esophageal cancer
Facts about Esophageal Cancer
- Esophagus cancer is the most rapidly increasing cancer in the US. It is estimated that it will kill almost 14,000 Americans in 2007. There will be 15-16,000 new cases diagnosed in 2007.[in 2000, there were about 12,000 new cases diagnosed]. About three fourths of the affected people are men.
- Esophagus cancer will be the number 7 cancer killer of men in 2007.
- Long-standing gastro-esophageal reflux(heartburn) is a predisposing factor for esophagus cancer.
- American at highest risk for Barrett’s esophagus and esophagus cancer: white men over 50 years with a long history of reflux.
New techniques are emerging to detest and treat affected people but we need to do better!